Immunogenicity and safety of the combined vaccine for measles, mumps, and rubella isolated or combined with the varicella component administered at 3-month intervals: randomised study

BACKGROUND: Field testing required to license the combined measles, mumps, and rubella (MMR) vaccine must take into account the current recommendation of the vaccine in Brazil: first dose at 12 months and second dose at 15 months of age in combination with a varicella vaccine. OBJECTIVES: This study...

Descripción completa

Detalles Bibliográficos
Autores principales: dos Santos, Eliane Matos, Noronha, Tatiana Guimarães, Alves, Isabelle Soares, Cruz, Robson Leite de Souza, Ferroco, Clara Lucy de Vasconcellos, Brum, Ricardo Cristiano, de Oliveira, Patricia Mouta Nunes, Siqueira, Marilda Mendonça, Lima, Mariza Cristina, Ramos, Francisco Luzio de Paula, Bragagnolo, Camila de Marco, Camacho, Luiz Antonio Bastos, Maia, Maria de Lourdes de Sousa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Instituto Oswaldo Cruz, Ministério da Saúde 2019
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6404515/
https://www.ncbi.nlm.nih.gov/pubmed/30843921
http://dx.doi.org/10.1590/0074-02760180517

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6404515/
https://www.ncbi.nlm.nih.gov/pubmed/30843921
http://dx.doi.org/10.1590/0074-02760180517

Ejemplares similares